Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCT4Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,743
Award facts
- Contract value 100% obligated
- $3,743.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors valued at $3,743.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply procurement supporting military healthcare systems worldwide.
AmerisourceBergen Drug Corp is one of the nation's largest pharmaceutical distributors and a critical vendor for federal medical procurement, particularly serving the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to deliver diverse pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic categories. The current award for Zepbound, a diabetes and weight management medication, reflects the company's role in supporting military personnel and beneficiary healthcare needs through the DLA's comprehensive pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCT4Q?
SPE2DR26FCT4Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FCT4Q worth?
The government has obligated $3,743 on SPE2DR26FCT4Q.
Is contract SPE2DR26FCT4Q an order under another contract?
Yes. SPE2DR26FCT4Q is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCT4Q competed?
The extent of competition for SPE2DR26FCT4Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award